NO20031928D0 - Nye krystall- og solvatformer av ondansetronhydroklorid og fremgangmsmåterfor fremstilling av disse - Google Patents

Nye krystall- og solvatformer av ondansetronhydroklorid og fremgangmsmåterfor fremstilling av disse

Info

Publication number
NO20031928D0
NO20031928D0 NO20031928A NO20031928A NO20031928D0 NO 20031928 D0 NO20031928 D0 NO 20031928D0 NO 20031928 A NO20031928 A NO 20031928A NO 20031928 A NO20031928 A NO 20031928A NO 20031928 D0 NO20031928 D0 NO 20031928D0
Authority
NO
Norway
Prior art keywords
preparation
methods
new crystal
ondansetron hydrochloride
solvate forms
Prior art date
Application number
NO20031928A
Other languages
English (en)
Other versions
NO20031928L (no
Inventor
Ramy Lidor-Hadas
Judith Aronhime
Revital Lifshitz
Shlomit Weizel
Valerie Niddam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031928D0 publication Critical patent/NO20031928D0/no
Publication of NO20031928L publication Critical patent/NO20031928L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO20031928A 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav NO20031928L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24428300P 2000-10-30 2000-10-30
US25381900P 2000-11-29 2000-11-29
US26553901P 2001-01-31 2001-01-31
PCT/US2001/048720 WO2002036558A2 (en) 2000-10-30 2001-10-30 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation

Publications (2)

Publication Number Publication Date
NO20031928D0 true NO20031928D0 (no) 2003-04-29
NO20031928L NO20031928L (no) 2003-06-27

Family

ID=27399743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031928A NO20031928L (no) 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav

Country Status (20)

Country Link
US (1) US20020107275A1 (no)
EP (1) EP1339707A2 (no)
JP (1) JP2004525083A (no)
KR (1) KR20030042038A (no)
CN (1) CN1498216A (no)
AU (1) AU2002230935A1 (no)
CA (1) CA2426026A1 (no)
CZ (1) CZ20031397A3 (no)
DE (1) DE01991193T1 (no)
ES (1) ES2204358T1 (no)
HR (1) HRP20030432A2 (no)
HU (1) HUP0401239A2 (no)
IL (1) IL155644A0 (no)
IS (1) IS6797A (no)
MX (1) MXPA03003761A (no)
NO (1) NO20031928L (no)
PL (1) PL366150A1 (no)
SK (1) SK6182003A3 (no)
WO (1) WO2002036558A2 (no)
YU (1) YU32003A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004526692A (ja) * 2001-01-11 2004-09-02 テバ ファーマシューティカル インダストリーズ リミティド 純粋な塩酸オンダンセトロン二水和物を製造するための改良された方法
PL373191A1 (en) 2002-04-29 2005-08-22 Teva Gyogyszergyar Reszvenytarsasag Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
US7547791B2 (en) * 2004-10-26 2009-06-16 Ipca Laboratories Ltd. One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O
EP2363117B1 (en) * 2006-01-27 2015-08-19 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
EP1976492B8 (en) * 2006-01-27 2018-07-04 Adare Pharmaceuticals, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20100105724A1 (en) * 2006-12-07 2010-04-29 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
MA39033A1 (fr) 2013-11-15 2017-11-30 Akebia Therapeutics Inc Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) * 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
PL373191A1 (en) * 2002-04-29 2005-08-22 Teva Gyogyszergyar Reszvenytarsasag Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법

Also Published As

Publication number Publication date
HRP20030432A2 (en) 2004-06-30
ES2204358T1 (es) 2004-05-01
SK6182003A3 (en) 2004-03-02
IS6797A (is) 2003-04-29
JP2004525083A (ja) 2004-08-19
PL366150A1 (en) 2005-01-24
EP1339707A2 (en) 2003-09-03
YU32003A (sh) 2006-05-25
CZ20031397A3 (cs) 2003-11-12
KR20030042038A (ko) 2003-05-27
CN1498216A (zh) 2004-05-19
HUP0401239A2 (hu) 2004-12-28
US20020107275A1 (en) 2002-08-08
NO20031928L (no) 2003-06-27
DE01991193T1 (de) 2004-07-08
WO2002036558A2 (en) 2002-05-10
WO2002036558A3 (en) 2003-02-06
AU2002230935A1 (en) 2002-05-15
MXPA03003761A (es) 2003-07-28
CA2426026A1 (en) 2002-05-10
IL155644A0 (en) 2003-11-23

Similar Documents

Publication Publication Date Title
NO20055211D0 (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20033387L (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
NO20030863L (no) Fremgangsmåte og anordning for sementering av brönner
NO20004439L (no) Fremgangsmåte og anordning for brönntesting
NO20030661D0 (no) Forbedret "logging-under-boring"-anordning og fremgangsmåte for måling av tetthet
DK1350921T3 (da) Fremgangsmåder og apparat til at klargöre og gruspakke bröndhuller
NO20023631D0 (no) Apparat og fremgangsmåte for brönnboring
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
NO20014504D0 (no) Anordning og fremgangsmåte for rehabilitering av tinnitus
NO20035326D0 (no) Anordning og fremgangsmåte for behandling med magnetfelt
NO20030668D0 (no) Apparat og metode for telemetri
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20031928D0 (no) Nye krystall- og solvatformer av ondansetronhydroklorid og fremgangmsmåterfor fremstilling av disse
NO20033251D0 (no) Fremgangsmåte for bestemmelse av den effektive mobilitet og permeabilitet for en formasjon på stedet
NO20040266L (no) Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20030843L (no) Anordning og fremgangsmåte for kultivering
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO20001539D0 (no) Framgangsmåte og anordning for måling av mikroskopisk vibrasjon
NO20030822L (no) Nye forbindelser og fremgangsmåter
PL365272A1 (en) Method and device for fabrication of foundation element
NO20030414L (no) Fremgangsmåte for fremstilling av brönnsement og tilhörende testanordning
NO20031272L (no) Fremgangsmåte og form for kald isopressing

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application